The mechanism of the cadmium-induced toxicity and cellular response in the liver
V Souza-Arroyo, JJ Fabián, L Bucio-Ortiz… - Toxicology, 2022 - Elsevier
Cadmium is a toxic element to which man can be exposed at work or in the environment.
Cd's most salient toxicological property is its exceptionally long half-life in the human body …
Cd's most salient toxicological property is its exceptionally long half-life in the human body …
The role of the ATP-binding cassette A1 (ABCA1) in human disease
L Jacobo-Albavera, M Domínguez-Pérez… - International journal of …, 2021 - mdpi.com
Cholesterol homeostasis is essential in normal physiology of all cells. One of several
proteins involved in cholesterol homeostasis is the ATP-binding cassette transporter A1 …
proteins involved in cholesterol homeostasis is the ATP-binding cassette transporter A1 …
Oxidative stress in NAFLD: role of nutrients and food contaminants
C Rives, A Fougerat, S Ellero-Simatos, N Loiseau… - Biomolecules, 2020 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is often the hepatic expression of metabolic
syndrome and its comorbidities that comprise, among others, obesity and insulin-resistance …
syndrome and its comorbidities that comprise, among others, obesity and insulin-resistance …
[HTML][HTML] Mitochondrial dysfunction: A promising therapeutic target for liver diseases
P Chen, L Yao, M Yuan, Z Wang, Q Zhang, Y Jiang… - Genes & …, 2024 - Elsevier
The liver is an important metabolic and detoxification organ and hence demands a large
amount of energy, which is mainly produced by the mitochondria. Liver tissues of patients …
amount of energy, which is mainly produced by the mitochondria. Liver tissues of patients …
Niemann–Pick type C disease: cellular pathology and pharmacotherapy
S Wheeler, DJ Sillence - Journal of neurochemistry, 2020 - Wiley Online Library
Niemann–Pick type C disease (NPCD) was first described in 1914 and affects approximately
1 in 150 000 live births. It is characterized clinically by diverse symptoms affecting liver …
1 in 150 000 live births. It is characterized clinically by diverse symptoms affecting liver …
[HTML][HTML] Cholesterol enrichment in liver mitochondria impairs oxidative phosphorylation and disrupts the assembly of respiratory supercomplexes
E Solsona-Vilarrasa, R Fucho, S Torres, S Nuñez… - Redox biology, 2019 - Elsevier
Mitochondrial cholesterol accumulation is a hallmark of alcoholic and non-alcoholic fatty
liver diseases and impairs the function of specific solute carriers through changes in …
liver diseases and impairs the function of specific solute carriers through changes in …
Mitochondrial Dysfunction in the Transition from NASH to HCC
M Léveillé, JL Estall - Metabolites, 2019 - mdpi.com
The liver constantly adapts to meet energy requirements of the whole body. Despite its
remarkable adaptative capacity, prolonged exposure of liver cells to harmful environmental …
remarkable adaptative capacity, prolonged exposure of liver cells to harmful environmental …
Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation
J Wu, L Guo, X Qiu, Y Ren, F Li, W Cui… - British Journal of Cancer, 2020 - nature.com
Background The liver is the central organ for cholesterol homoeostasis, and its dysfunction
might cause liver pathological alterations including hepatocellular carcinomas (HCCs). 3β …
might cause liver pathological alterations including hepatocellular carcinomas (HCCs). 3β …
Caffeine inhibits NLRP3 inflammasome activation by downregulating TLR4/MAPK/NF-κB signaling pathway in an experimental NASH model
EE Vargas-Pozada, E Ramos-Tovar… - International Journal of …, 2022 - mdpi.com
Caffeine elicits protective effects against liver diseases, such as NASH; however, its
mechanism of action involving the pyrin domain-containing-3 (NLRP3) inflammasome …
mechanism of action involving the pyrin domain-containing-3 (NLRP3) inflammasome …
Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis
Objective Liver fibrosis is part of the non-alcoholic fatty liver disease (NAFLD) spectrum,
which currently has no approved pharmacological treatment. In this study, we investigated …
which currently has no approved pharmacological treatment. In this study, we investigated …